Nancy E. LePard

765 total citations
10 papers, 371 citations indexed

About

Nancy E. LePard is a scholar working on Immunology, Cancer Research and Oncology. According to data from OpenAlex, Nancy E. LePard has authored 10 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Nancy E. LePard's work include Immune cells in cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Immune Response and Inflammation (2 papers). Nancy E. LePard is often cited by papers focused on Immune cells in cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Immune Response and Inflammation (2 papers). Nancy E. LePard collaborates with scholars based in Canada. Nancy E. LePard's co-authors include Ralph E. Durand, Kevin L. Bennewith, Melisa J. Hamilton, Elizabeth C. Halvorsen, Jenna L. Collier, Judit P. Banáth, Cathie Garnis, James Jabalee, Christopher Td Dickman and James Lawson and has published in prestigious journals such as The Journal of Immunology, International Journal of Radiation Oncology*Biology*Physics and Oncotarget.

In The Last Decade

Nancy E. LePard

10 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy E. LePard Canada 9 157 144 144 121 48 10 371
Cristina Corbetta Italy 6 128 0.8× 118 0.8× 61 0.4× 150 1.2× 53 1.1× 9 351
Aurélie Thuleau France 10 101 0.6× 179 1.2× 108 0.8× 180 1.5× 42 0.9× 15 378
Raquel J. Nunes Portugal 8 164 1.0× 138 1.0× 68 0.5× 110 0.9× 22 0.5× 14 387
Francis G Gabriel United Kingdom 9 99 0.6× 142 1.0× 77 0.5× 165 1.4× 19 0.4× 11 358
Roland Stein Germany 11 167 1.1× 105 0.7× 103 0.7× 278 2.3× 35 0.7× 17 475
Jonathan Lerner United States 6 110 0.7× 162 1.1× 50 0.3× 110 0.9× 60 1.3× 7 441
Gunjan Mandal India 9 203 1.3× 221 1.5× 133 0.9× 218 1.8× 35 0.7× 19 490
Evi Horn Germany 7 153 1.0× 163 1.1× 104 0.7× 156 1.3× 15 0.3× 8 403
Seog Young Kim South Korea 7 68 0.4× 129 0.9× 77 0.5× 203 1.7× 16 0.3× 9 327
Amato Giaccia United States 5 74 0.5× 235 1.6× 289 2.0× 136 1.1× 58 1.2× 6 486

Countries citing papers authored by Nancy E. LePard

Since Specialization
Citations

This map shows the geographic impact of Nancy E. LePard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. LePard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. LePard more than expected).

Fields of papers citing papers by Nancy E. LePard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy E. LePard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. LePard. The network helps show where Nancy E. LePard may publish in the future.

Co-authorship network of co-authors of Nancy E. LePard

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy E. LePard. A scholar is included among the top collaborators of Nancy E. LePard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy E. LePard. Nancy E. LePard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bosiljcic, Momir, Rachel A. Cederberg, Melisa J. Hamilton, et al.. (2019). Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs. Breast Cancer Research. 21(1). 103–103. 62 indexed citations
2.
Dickman, Christopher Td, James Lawson, James Jabalee, et al.. (2017). Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes. Oncotarget. 8(9). 15252–15266. 71 indexed citations
3.
Halvorsen, Elizabeth C., Melisa J. Hamilton, Brennan J. Wadsworth, et al.. (2016). Maraviroc decreases CCL8-mediated migration of CCR5+regulatory T cells and reduces metastatic tumor growth in the lungs. OncoImmunology. 5(6). e1150398–e1150398. 82 indexed citations
4.
Hamilton, Melisa J., Elizabeth C. Halvorsen, Nancy E. LePard, et al.. (2015). SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice. Oncotarget. 7(4). 3677–3691. 9 indexed citations
5.
Hamilton, Melisa J., Momir Bosiljcic, Nancy E. LePard, et al.. (2013). Macrophages Are More Potent Immune Suppressors Ex Vivo Than Immature Myeloid-Derived Suppressor Cells Induced by Metastatic Murine Mammary Carcinomas. The Journal of Immunology. 192(1). 512–522. 32 indexed citations
6.
Hamilton, Melisa J., Judit P. Banáth, Vivian Lam, et al.. (2011). Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice. Cancer Immunology Immunotherapy. 61(5). 643–654. 13 indexed citations
7.
Durand, Ralph E. & Nancy E. LePard. (2000). Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice. Radiotherapy and Oncology. 56(2). 245–252. 7 indexed citations
8.
Durand, Ralph E. & Nancy E. LePard. (1997). Tumour blood flow influences combined radiation and doxorubicin treatments. Radiotherapy and Oncology. 42(2). 171–179. 21 indexed citations
9.
Durand, Ralph E. & Nancy E. LePard. (1995). Contribution of Transient Blood Flow to Tumour Hypoxia in Mice. Acta Oncologica. 34(3). 317–323. 55 indexed citations
10.
Durand, Ralph E. & Nancy E. LePard. (1994). Modulation of tumor hypoxia by conventional chemotherapeutic agents. International Journal of Radiation Oncology*Biology*Physics. 29(3). 481–486. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026